Pfizer Has Cash To Burn — So It Might Buy This Soaring Biotech
Rumors that Pfizer (PFE) is in "advanced talks" to acquire Global Blood Therapeutics (GBT) for about $5 billion sent GBT stock flying for a second consecutive day Friday.
X
Global Blood Therapeutics makes a sickle cell disease…